| 1 |
35328549 | Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma. | 2022 Mar 14 |
3 |
| 2 |
34198834 | Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells. | 2021 Jun 5 |
1 |
| 3 |
31865754 | A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer. | 2020 Dec |
1 |
| 4 |
32396749 | The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells. | 2020 Dec |
3 |
| 5 |
32738591 | A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches. | 2020 Oct |
1 |
| 6 |
30433782 | 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles. | 2018 Dec 13 |
1 |
| 7 |
25875209 | 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. | 2015 May 14 |
1 |